Key Info

Basic Information

Prof. Dr. Nikolaus Marx
Faculty / Institution:
Project duration:
01.01.2020 to 31.12.2022
EU contribution:
2.998.875 euros


Real-World Cardio-Respiratory Health Monitoring for Clinical Contract Research & Telecardiology


RealWorld4Clinic will accelerate market launch of a coin-sized medical device anchored to the fundus of the stomach. There it acquires real-life cardio-respiratory health data for exploitation in drug development and tele-cardiology. The clinical trial market will be the stepping stone towards outpatient cardiological care – our priority market. We enrich the device by remote monitoring and data exploitation, training & education, and outcome prediction & performance measurement tools. Co-creation at the hearts of clinical contract research & clinical cardiology ensures patient comfort, workflow compatibility and policy compliance. Our ambition is to make a significant impact on the real-world effectiveness of treatments by pursuing the convergence of clinical research & clinical care. We will improve the predictive power of clinical trials by 50 percent and halve the rate of emergency hospitalisations in heart failure patients – leveraging savings in the amount of billions of euros.


  • Profil GmbH, Germany (Coordinator)
  • INSERM – French National Institute of Health and Medical Research, France
  • Universitätsklinikum Aachen, Germany
  • Université Grenoble Alpes, France
  • CHUGA, France
  • SentinHealth, France
  • Fraunhofer Gesellschaft, Germany
  • Grenoble Ecole Management (GEM), France
  • MADoPA, France
  • Comarch, Poland


  Logo EIT Health

This activity has received funding from the European Institute of Innovation and Technology (EIT), a body of the European Union, under the Horizon 2020, the EU Framework Programme for Research and Innovation.